CD163 and type 2 diabetes mellitus: Moreover, elevated sCD163 concentrations were associated with an increase in HDL cholesterol (β = 1.390, p = 0.034), triglycerides (β = 1.152, p = 0.017), the prescription of β-blockers (β = 1.313, p = 0.006), and, partly, with T2D treatment (β = 1.225, p = 0.055).